NDA supported by data from global Phase III FRESCO-2 study in the U.S., Europe, Japan and Australia along with data from Phase III FRESCO study conducted in China
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The order marks a significant milestone for MMP Industries that will contribute to the company's revenue in the coming financial year
Brimonidine Tartrate Ophthalmic Solution is an alpha adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure
The facility is over 79,000 square feet and is equipped with packaging lines
Valbenazine Capsules (RLD Ingrezza) had estimated annual sales of USD 1,235 million in the U.S. (IQVIA MAT December 2022).
The inspection included a comprehensive scrutiny of practices and procedures for reporting of adverse events of Lupin’s marketed products worldwide
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
Obeticholic Acid Tablets (RLD Ocaliva) had estimated annual sales of US $255 million in the US (IQVIA MAT December 2022).
Subscribe To Our Newsletter & Stay Updated
